Clinical Trials List
2023-10-05 - 2027-12-31
Phase II
Recruiting6
ICD-10C16.0
Malignant neoplasm of cardia
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.0
Malignant neoplasm of cardia of stomach
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Ching Chen 無
- 王秀慈 無
- Chang-Fang Chiu 無
- 王幸婷 無
- 陳珈妤 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Yin Wu 無
- 顏志傑 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- SUNG-HSIN KUO 無
- TA-CHEN HUANG 無
- 梁逸歆 無
- TSUNG-HAO LIU 無
- 林宗哲 無
- 呂理駿 無
- 李佳真 無
- 莊建淮 無
- 郭弘揚 無
- 張端瑩 無
- Hsiang-Fong Kao 無
- 陳國興 無
- Ying-Chun Shen 無
- YU-YUN SHAO 無
- Chih-Hung Hsu 無
- Ann-Lii Cheng 無
- 陳柏邑 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsai-Sheng Yang 無
- Ming-Mo Hou 無
- Chan-Keng Yang 無
- Wen-Chi Shen 無
- Po-Jung Su 無
- Hung-Chih Hsu 無
- 余紹銘 無
- Wen-Chi Chou 無
- 黃文冠 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14 participants
-
Global
210 participants
